We extensively review the available evidence pertaining to the influence of insulin secretion and sensitivity, obesity, autoimmunity, lifestyle, growth hormone, and sex hormone replacement therapy on the occurrence of DM in these patients. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.